NRIX
NURIX THERAPEUTI
Health Care·Biotechnology·UNITED STATES
$27.05
MCap —
as of 2026-08-20
Total
C8w
Fund
E9w
Quant
A8w
Price
▲ Up▼ Down━ MA30━ MA100━ Mean┄ U┄ L
MIDOS % pane · green > 90 long zone · red < 10 short zone · reference lines at 10 / 90
MIDOS SI
as of 2026-08-20
MIDOS SI
-1.23
Sentiment 92.0%— long zone
−3 oversold0+3 overbought
Signal
BEARISH
Actual
$27.05
Adaptive Mean
$27.78
-0.73 vs mean
Adaptive σ
0.30
MIDOS BB
$27.18 – $28.37
center ± 2σ adaptive
Fundamental Factors (Sector-Relative Z)
as of 2026-08-21
Composite Z
-0.44
ROE
-80.3%
Z -0.80
Rev Gr
-79.5%
Z -0.86
EPS Gr
—
Z -0.10
OPM Gr
-932.1%
Z —
FCF Yld
-5.8%
Z -0.99
EPS Surp
-0.1%
Z -0.14
EPS 3mo Δ
596.5%
Z +0.24
Fwd P/E
-18.91
Z —
PEGY
N/A
growth + yield ≤ 0
Momentum (Risk-Adjusted Alpha)
as of 2026-08-21
Q3M
20.58
Q6M
10.23
Q12M
9.01
MA 30/100
1.249
Bullish (MA30 > MA100)
α (Jensen)
1.9968
β (12M)
1.53
σ (12M)
0.616
Momentum inflection: Q3M > Q12M
Divergence — Fundamentals vs Momentum
Z Percentile
11%
Q Percentile
95%
Divergence
-84.0
Tier
TRIM — ACT
Momentum well ahead of fundamentals. Trim candidate.
Kirkpatrick RS & Persistence
RS
61.2
RS Pctl
94%
RS Decile
D10
Persistence
8w
at grade C
Options / OI Analysis
No options or Williams data available for this ticker.